Sibley DR - Search Results

1

D5 dopamine receptors are required for dopaminergic activation of phospholipase C.

Sahu A, Tyeryar KR, Vongtau HO, Sibley DR, Undieh AS. Sahu A, et al. Among authors: sibley dr. Mol Pharmacol. 2009 Mar;75(3):447-53. doi: 10.1124/mol.108.053017. Epub 2008 Dec 1. Mol Pharmacol. 2009. PMID: 19047479 Free PMC article.

2

Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

Monsma FJ Jr, Shen Y, Ward RP, Hamblin MW, Sibley DR. Monsma FJ Jr, et al. Among authors: sibley dr. Mol Pharmacol. 1993 Mar;43(3):320-7. Mol Pharmacol. 1993. PMID: 7680751

3

The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.

Zhang LJ, Lachowicz JE, Sibley DR. Zhang LJ, et al. Among authors: sibley dr. Mol Pharmacol. 1994 May;45(5):878-89. Mol Pharmacol. 1994. PMID: 7910658

4

D1-like dopaminergic activation of phosphoinositide hydrolysis is independent of D1A dopamine receptors: evidence from D1A knockout mice.

Friedman E, Jin LQ, Cai GP, Hollon TR, Drago J, Sibley DR, Wang HY. Friedman E, et al. Among authors: sibley dr. Mol Pharmacol. 1997 Jan;51(1):6-11. doi: 10.1124/mol.51.1.6. Mol Pharmacol. 1997. PMID: 9016340

5

Regulation of D(1) dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization.

Jiang D, Sibley DR. Jiang D, et al. Among authors: sibley dr. Mol Pharmacol. 1999 Oct;56(4):675-83. Mol Pharmacol. 1999. PMID: 10496949

6

The role of phosphorylation/dephosphorylation in agonist-induced desensitization of D1 dopamine receptor function: evidence for a novel pathway for receptor dephosphorylation.

Gardner B, Liu ZF, Jiang D, Sibley DR. Gardner B, et al. Among authors: sibley dr. Mol Pharmacol. 2001 Feb;59(2):310-21. doi: 10.1124/mol.59.2.310. Mol Pharmacol. 2001. PMID: 11160868

7

The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4.

Rankin ML, Marinec PS, Cabrera DM, Wang Z, Jose PA, Sibley DR. Rankin ML, et al. Among authors: sibley dr. Mol Pharmacol. 2006 Mar;69(3):759-69. doi: 10.1124/mol.105.019901. Epub 2005 Dec 7. Mol Pharmacol. 2006. PMID: 16338988

8

D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms.

Chun LS, Free RB, Doyle TB, Huang XP, Rankin ML, Sibley DR. Chun LS, et al. Among authors: sibley dr. Mol Pharmacol. 2013 Aug;84(2):190-200. doi: 10.1124/mol.113.085175. Epub 2013 May 16. Mol Pharmacol. 2013. PMID: 23680635 Free PMC article.

9

Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.

Free RB, Chun LS, Moritz AE, Miller BN, Doyle TB, Conroy JL, Padron A, Meade JA, Xiao J, Hu X, Dulcey AE, Han Y, Duan L, Titus S, Bryant-Genevier M, Barnaeva E, Ferrer M, Javitch JA, Beuming T, Shi L, Southall NT, Marugan JJ, Sibley DR. Free RB, et al. Among authors: sibley dr. Mol Pharmacol. 2014 Jul;86(1):96-105. doi: 10.1124/mol.113.090563. Epub 2014 Apr 22. Mol Pharmacol. 2014. PMID: 24755247 Free PMC article.

10

Dopamine D₁-like receptors regulate the α₁A-adrenergic receptor in human renal proximal tubule cells and D₁-like dopamine receptor knockout mice.

Ennis RC, Asico LD, Armando I, Yang J, Feranil JB, Jurgens JA, Escano CS Jr, Yu P, Wang X, Sibley DR, Jose PA, Villar VA. Ennis RC, et al. Among authors: sibley dr. Am J Physiol Renal Physiol. 2014 Dec 1;307(11):F1238-48. doi: 10.1152/ajprenal.00119.2014. Epub 2014 Oct 22. Am J Physiol Renal Physiol. 2014. PMID: 25339698 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters